Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer.

Ther Clin Risk Manag · 2018 · PMC5896684 · PMID 29670357

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significancep =0.06so close (0.05 < p ≤ 0.1)

Borderline significance, as related to dronabinol’s effect on mood, was reported between 2.5 mg BID and 2.5 mg daily ( p =0.06) as well as between 2.5 and 5 mg BID ( p =0.05).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.